Browsing Tag
HealthQuest Capital
3 posts
Thyme Care crosses $2bn valuation as $7bn oncology platform expands into new businesses
Thyme Care has secured more than $125 million from Morgan Health, Humana, CVS Health Ventures and other investors at a valuation above $2 billion. The company is already profitable, reaches 10.5 million people and manages more than $7 billion of oncology spending. Its next move is more ambitious: turning the cancer-care platform into a parent company that can attack drug costs, biosimilar adoption and clinical-trial access.
HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever
HistoSonics, a trailblazer in non-invasive histotripsy technology, has successfully concluded an oversubscribed $102 million Series D financing round.…
Epilog Partners snaps up Care Connectors Medical Group
Epilog Partners, a private equity platform specialising in healthcare investments, has announced a significant acquisition of Care Connectors…